Methods for assessing therapeutic intervention success, health and longevity
By isolating and analyzing extracellular vesicles for specific biomarkers, the method addresses the challenge of monitoring molecular health benefits and intervention efficacy, offering a precise and predictive assessment of longevity and health outcomes.
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- DUKE UNIV
- Filing Date
- 2025-11-18
- Publication Date
- 2026-05-21
AI Technical Summary
Current methods lack the ability to effectively monitor exercise-induced health benefits at the molecular level and personalize therapeutic interventions for longevity and overall health, particularly through the use of extracellular vesicles as biomarkers.
Isolate extracellular vesicles from plasma samples, analyze them for specific biomarkers such as peptides and proteins, and compare their levels to control levels to assess longevity or overall health, and evaluate the efficacy of therapeutic interventions by comparing pre- and post-intervention biomarker levels.
Provides a minimally invasive method for assessing longevity and overall health, predicting survival, and evaluating therapeutic intervention efficacy using extracellular vesicle biomarkers, achieving high predictive accuracy and enabling personalized treatment approaches.
Smart Images
Figure US2025055926_21052026_PF_FP_ABST